New CDC Findings Show Protection From Booster Wanes After About Four Months

February 16, 2022 by Alexa Hornbeck
<strong>New CDC Findings Show Protection From Booster Wanes After About Four Months</strong>

Two new studies from the U.S. Centers for Disease Control and Prevention show the effectiveness of booster shots for combatting the omicron variant declines substantially after four months.

The first study examines hospitalizations and emergency room and urgent care center visits in 10 states from August 2021 to Jan. 22, 2022. The second study involves data from two CDC vaccine safety monitoring systems.

Data from the two studies provides evidence that the Pfizer-BioNTech and Moderna booster shots are 91% effective at preventing hospitalization for two months after receiving the shot; after four months, that protection dropped to 78%; and after five months, it fell to around 31%.  

Although the research is largely based on estimates, the studies still provide proof that protection from COVID-19 boosters wanes after about four months, signaling the possible need for more boosters in the future. 

Already, about 91 million Americans have received a booster dose of a COVID-19 vaccine, but according to data from the CDC most U.S. residents who are eligible for boosters still have not received them. 

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

April 18, 2024
by Beth McCue
Salmonella Outbreak Linked to Fresh Basil 

ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic... Read More

ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic basil. As of the alert, 12 Salmonella cases in seven states have been reported. There are no reported deaths. The basil was sold at Trader Joe’s... Read More

April 17, 2024
by Dan McCue
Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

Idaho's Ban on Youth Gender-Affirming Care Has Families Desperately Scrambling for Solutions

Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when... Read More

Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the now-16-year-old find happiness again, her father said. A decision by the... Read More

Weedkiller Manufacturer Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer

DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been... Read More

DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer. Nearly identical bills... Read More

April 16, 2024
by Dan McCue
Agency Sets Rules Limiting Miners’ Exposure to Hazardous Silica Dust

WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s... Read More

WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s miners from health hazards associated with exposure to respirable crystalline silica, also known as silica dust.  Inhaling crystalline silica, a known carcinogen, can cause serious lung... Read More

Biden Administration Announces Partnership With 50 Countries to Stifle Future Pandemics

WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal... Read More

WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the COVID-19 outbreak that suddenly halted normal life around the globe in 2020. U.S. government officials will work with the countries to develop better testing, surveillance,... Read More

News From The Well
scroll top